Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2001
11/21/2001EP0892792B1 Process to prepare oxazolidinones
11/21/2001CN1323291A Diaminopropionic acid derivatives
11/21/2001CN1322526A Compound for treating female sexual dysfunction
11/21/2001CN1322524A Use of pentanoate derivant
11/21/2001CN1075069C Synthesis of 3-[4-(2-aminoethoxy)-benzoyl)-2-aryl-6-hydroxybenzo(b) thiophenes
11/15/2001WO2001085706A1 Substituted phenylacetamides and their use as glucokinase activators
11/15/2001WO2001085694A2 Substituted diamide derivatives useful as motilin antagonists
11/15/2001WO2001085680A2 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
11/15/2001WO2001085678A1 Method for the production of $g(v)-aminoalkylsulphonic acids
11/15/2001WO2001008672A3 Glucamine compounds for treating hepatitis virus infections
11/15/2001US20010041814 Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
11/15/2001US20010041718 Cis-6-(4-fluoro-phenyl)-5-(4-(2-piperidin-1-yl-ethoxy)-phenyl) -5,6,7,8-tetrahydronaphthalene-2-ol, for example, and other estrogen agonists/antagonists to treat rheumatoid arthritis, colon cancer, wounds, cataracts and skin wrinkles
11/15/2001US20010041704 N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-4-phenylbutyl) -piperazinyl)acetamide, for example; useful to protect skeletal muscles against damage from trauma or disease, treat shock, preserve donor tissue or organs; greater half-life
11/15/2001US20010041700 A carbamoyl or S=C(NH) group containing nitrile derivatives, useful as cysteine protease inhibitor
11/15/2001CA2408288A1 Novel substituted diamine derivatives useful as motilin antagonists
11/14/2001CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors
11/13/2001US6316622 Process for preparing cis-2,6-dimethylpiperazine
11/13/2001US6316617 For treating physiological disorders associated with an excess of neuropeptide y, such as feeding disorders and certain cardiovascular diseases, medical diagnosis
11/13/2001US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001US6316484 Pentafluorobenzenesulfonamides and analogs
11/13/2001US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001US6316475 Treatment of cancer, asthma, heart diseases, seizures, inflammation
11/13/2001US6316470 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
11/13/2001US6316450 Compounds
11/13/2001US6316440 Reduced dipeptide analogues as calcium channel antagonists
11/13/2001US6316380 One transition metal compound and at least one n-heterocyclic carbene or its protonated salt
11/13/2001CA2171728C Triaryl-ethylene derivatives for use in therapy
11/08/2001WO2001083665A1 Wet wipes containing cationic fatty acid surfactants
11/08/2001WO2001083571A2 Catalysts containing n-pyrrolyl substituted nitrogen donors
11/08/2001WO2001083567A2 Nitroaromatic solubilizer for nitroxyls in aromatic solvents
11/08/2001WO2001083445A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/08/2001WO2001083436A2 Small technetium-99m and rhenium labeled agents and methods for imaging tumors
11/08/2001WO2001083433A1 Bifunctional inhibitors of malarial proteases and uses thereof
11/08/2001WO2001083427A1 PPARη MODULATORS
11/08/2001WO2001082925A1 Melanin concentrating hormone antagonists
11/08/2001WO2001082923A1 Estrogen receptor modulators
11/08/2001US20010039247 Pesticidal compositions
11/08/2001CA2407692A1 Catalysts containing n-pyrrolyl substituted nitrogen donors
11/08/2001CA2407587A1 Ppar.gamma. modulators
11/08/2001CA2404975A1 Wet wipes containing cationic fatty acid surfactants
11/08/2001CA2377629A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/07/2001EP1151998A1 Estrogen agonists/antagonists
11/07/2001EP1150970A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
11/07/2001EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
11/07/2001EP1150944A1 N2-phenylamidine derivatives
11/07/2001EP1150937A1 Liquid crystalline trifluoro-substituted compounds
11/07/2001CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001US6313307 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
11/06/2001US6313297 Base-catalyzed synthesis of 1-aryl-4-(aryl ethyl)piperazines from aromatic olefins and 1-arylpiperazines
11/06/2001US6313294 Solvent-free amidation reaction of molten secondary alkylenediamine and ester to form tertiary amide; one step; noncatalytic reaction
11/06/2001US6313293 Preparation of amides and quinazoline derivatives
11/06/2001US6313166 Used for pest control, as microbicides, insecticides and acaricides in agriculture, horticulture and in hygiene sector
11/06/2001US6313162 Propynyl or dienyl biaromatic compounds
11/06/2001US6313150 α-substituted phenylacetic acid derivative, its production and agricultural fungicide containing it
11/06/2001US6313123 Acetylenic sulfonamide thiol tace inhibitors
11/06/2001US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001US6313120 Treatment or prevention of diseases involving bradykinin receptors
11/06/2001US6313118 Hydroxytryptamine receptor antagonists
11/06/2001US6313117 Succinate derivative compounds useful as cysteine protease inhibitors
11/06/2001US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers
11/01/2001WO2001081355A1 Combretastatin a-1 phosphate and combretastatin b-1 phosphate prodrugs
11/01/2001WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001US20010037042 Using monophosphine palladium complex catalyst
11/01/2001US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001US20010037011 Reacting a carboxylic acid with an amine carboxylate salt, in presence of inorganic base, wherein the salt product of inorganic base cation and the carboxylate anion has a solubility in water of polar solvent less or equal 5/100
11/01/2001CA2407663A1 Inhibitors of dipeptidyl peptidase iv
10/2001
10/31/2001EP1149843A1 Substituted phenethylamine derivatives
10/31/2001EP1149083A1 Morpholinobenzamide salts
10/31/2001EP1149076A1 O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically acceptable salts and process for preparing the same
10/31/2001EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001EP1149063A2 Ureido-thiobutyric acid derivatives as ppar-agonists
10/31/2001EP1148880A2 Methods for restoring and/or enhancing accommodation in pseudo phakia
10/31/2001EP0773929B1 Piperidine derivatives as neurokinin antagonists
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/30/2001US6310246 Fluorovinloxyacetamides, process for preparing same and herbicidal composition comprising same
10/30/2001US6310107 (+)-6-(4-biphenylyl)methoxy-2-(2-(n,n-dimethylamino)ethyl)tetr alin, or a salt is useful for inhibiting production and/or secretion of amyloid-beta protein
10/30/2001US6310096 Cyclohexadiene-derivatives as pesticides
10/30/2001US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001US6310060 For use as antiproliferative agent for use against cancer, psoriasis, restenosis, autoimmune disease, or atherosclerosis
10/30/2001US6310059 Constrained fused ring derivatives of piperidine or piperazine linked to hydrophobic substituents which enhance calcium channel blocking activity; combinatorial libraries for drug screening
10/30/2001CA2113189C Diaminic compounds, preparation, use and intermediates
10/25/2001WO2001079189A2 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/25/2001WO2001079188A1 Antihistaminic compounds
10/25/2001WO2001079161A1 NOVEL α-SULFIN- AND α-SULFONAMINO ACID AMIDE DERIVATIVES
10/25/2001WO2001079160A1 Alpha-sulfin- and alpha-sulfonamino acid amide derivatives
10/25/2001WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001WO2001079155A2 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
10/25/2001WO2001078733A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
10/25/2001WO2001078697A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001US20010034464 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst
10/25/2001US20010034447 N-(5-tert-butyl-2-methoxyphenyl)-n'-(4-(1-oxoisoindolin-5-ylox y)penyl)urea as anticarcinogenic agents
10/25/2001US20010034341 Bactericides
10/25/2001CA2406903A1 Alpha-sulfin- and alpha-sulfonamino acid amide derivatives
10/25/2001CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001CA2405684A1 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
10/25/2001CA2405233A1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001CA2404263A1 Novel .alpha.-sulfin- and .alpha.-sulfonamino acid amide derivatives
10/24/2001EP1147098A1 Compounds comprising acrylate and cyclic sec.-amine functionalities